Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 24, 2022
GNS and Servier announced a collaboration to advance drug discovery, translational, and clinical development efforts in Multiple Myeloma (MM).
read more
Lonza expanded the range of particle engineering services offered by its Monteggio (CH) site through the introduction of X-ray powder diffraction (XRPD).
read more
Wednesday, August 17, 2022
ProBioGen closed a Master Service Agreement with NextPoint and initiated development and GMP manufacturing of their lead antibody candidate.
read more
Orientation Marketing, a pharmaceutical and life science marketing agency, opened a new office in Espoo, Finland to serve its growing client base in the Nordic and EU regions.
read more
Gerresheimer announced investments to rapidly expand manufacturing, supply and logistics capacity for glass vials in the U.S. The project will be supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
read more
On July 18, 2022, Neil Jones joined Aenova as the new Chief Commercial Officer (CCO) of Aenova Group.
read more
Azenta entered an agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"). B Medical is a provider of temperature-controlled storage and transportation solutions globally.
read more
Thursday, August 04, 2022
Curia has appointed Niall Condon as president of its Manufacturing Division. Condon will drive growth and be responsible for operations of Curia’s commercial manufacturing services and products, including API and Drug Product.
read more
Thursday, August 04, 2022
Evonik is building a new cGMP facility to manufacture lipids for clinical development and launch of innovative medicines. The new cGMP lipid launch facility is located in Hanau, Germany and will provide customers with smaller batch sizes of lipids as...
read more
Samsung Biologics, a leading contract development and manufacturing organization, announced strong financial results for the second quarter of 2022.
read more
GreenLight Biosciences and Samsung Bio announced the successful completion of their first commercial-scale mRNA engineering run.
read more
Inotiv announced an expanded capacity to conduct Good Laboratory Practices (“GLP”) studies for in vitro cytogenetics and bacterial mutation assays as components of the Standard Battery of genetic toxicology studies required for first-in-human ...
read more
Soleo Health is now a limited distribution partner for the cardiovascular drug LEQVIO®, manufactured by Novartis.
read more
CoreRx, Inc. announced the appointment of Dan Dobry as Chief Strategy Officer and a member of CoreRx’s Executive Leadership Team. Dan will report to CoreRx’s Chief Executive Officer, Ajay Damani.
read more
Piramal Pharma Limited’s Pharma Solutions business, held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company’s site in Aurora, Ontario.
read more